Difference between revisions of "Part:BBa K4488031"
Line 9: | Line 9: | ||
Our project demonstrated that anti-sfGFP nanobody 7 binds to sfGFP through a GFP bindings assay. Therefore, nanobody 7 can be effectively surface displayed using Neae-intimin which provides preliminary evidence that other types of nanobodies can be displayed and later selected using the same construct. | Our project demonstrated that anti-sfGFP nanobody 7 binds to sfGFP through a GFP bindings assay. Therefore, nanobody 7 can be effectively surface displayed using Neae-intimin which provides preliminary evidence that other types of nanobodies can be displayed and later selected using the same construct. | ||
− | [[File: Binding of anti-fuGFP Nanobodies to GFPs (400nm) .png|centre|thumb| Figure 1: Binding of anti-GFP nanobodies H, 2, 3, 6 and 7 to sfGFP, fuGFP and eGFP, measured on the plate reader at 400nm (full settings can be found <span class="plainlinks">[https://2022.igem.wiki/sydney-australia/protocols here]</span>). Measurements at 400nm are taken to optimise for fuGFP fluorescence. This graph shows no significant binding to fuGFP when compared to the Neae negative control.]] | + | [[File: Binding of anti-fuGFP Nanobodies to GFPs (400nm) .png|centre|thumb|700px| Figure 1: Binding of anti-GFP nanobodies H, 2, 3, 6 and 7 to sfGFP, fuGFP and eGFP, measured on the plate reader at 400nm (full settings can be found <span class="plainlinks">[https://2022.igem.wiki/sydney-australia/protocols here]</span>). Measurements at 400nm are taken to optimise for fuGFP fluorescence. This graph shows no significant binding to fuGFP when compared to the Neae negative control.]] |
− | [[File: Binding of anti-fuGFP Nanobodies to GFPs (470nm) .png|centre|thumb| Figure 2: Binding of anti-GFP nanobodies H, 2, 3, 6 and 7 to sfGFP, fuGFP and eGFP, measured on the plate reader at 470nm (full settings can be found <span class="plainlinks">[https://2022.igem.wiki/sydney-australia/protocols here]</span>). This graph shows significant binding to sfGFP for nanobodies H, 2, 3 and 7 when compared to Neae negative control. Nanobody 6 does not appear to bind sfGFP more than the negative control. Nanobody H appears to bind the most to sfGFP.]] | + | [[File: Binding of anti-fuGFP Nanobodies to GFPs (470nm) .png|centre|thumb|700px| Figure 2: Binding of anti-GFP nanobodies H, 2, 3, 6 and 7 to sfGFP, fuGFP and eGFP, measured on the plate reader at 470nm (full settings can be found <span class="plainlinks">[https://2022.igem.wiki/sydney-australia/protocols here]</span>). This graph shows significant binding to sfGFP for nanobodies H, 2, 3 and 7 when compared to Neae negative control. Nanobody 6 does not appear to bind sfGFP more than the negative control. Nanobody H appears to bind the most to sfGFP.]] |
<!-- --> | <!-- --> | ||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> |
Latest revision as of 03:24, 12 October 2022
Neae-intimin Construct Displaying anti-sfGFP Nanobody 2
Surface display of anti-sfGFP nanobody 2 using the bacterial protein Neae-intimin. The nanobody is a modification of GenBank ID: AIF28002. There is a linker between the Neae-intimin gene and the nanobody sequence. It has been optimised to express in pUS250 TOP10 E.coli.
Usage and Biology
Our project demonstrated that anti-sfGFP nanobody 7 binds to sfGFP through a GFP bindings assay. Therefore, nanobody 7 can be effectively surface displayed using Neae-intimin which provides preliminary evidence that other types of nanobodies can be displayed and later selected using the same construct.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]